Lipidomic Profiling in Pancreatic Cancer Treatment ID: 2016-054
This study explores the potential of lipidomic profiling to inform and enhance pancreatic cancer treatment strategies.
Photo by Sebastian Kaulitzki - stock.adobe.com
Technology Overview
The document delves into the significance of lipidomic profiling, specifically focusing on sphingosine kinase activity and its role in pancreatic cancer cell survival and resistance to apoptosis. It highlights an imbalance in lipid levels, suggesting that targeting the sphingosine kinase pathway could improve chemotherapeutic outcomes.
Key Advantages
- Offers a novel approach to understanding pancreatic cancer mechanisms
- Identifies potential targets for enhancing chemotherapeutic efficacy
- Provides a basis for personalized cancer treatment strategies
- Utilizes mass spectrometry-based lipidomic analyses for detailed lipid profiling
Problems Addressed
- Challenges in treating pancreatic cancer due to resistance to apoptosis
- Lack of targeted therapies for specific enzymatic pathways in cancer cells
- Difficulty in identifying effective combination therapies for cancer treatment
Market Applications
- Development of sphingosine kinase inhibitors as adjunct therapy in cancer treatment
- Personalized cancer treatment plans based on lipidomic profiles of tumors
- Enhancement of existing chemotherapeutic regimes through targeted therapy
Additional Information
Technology ID: 2016-054
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report